\-\ Texto\\:\\ \ \(0\)\
\-\ ataxia\\.\\ \\ no\\ focal\\ neurological\\ deficit\\.\ \(0\)\
\-\ surgical\\ excision\\.\\ chemotherapy\\ pending\ \(0\)\
\-\ \\â\\€\\¢\\ enhancing\\ intraventricular\\ mass\\ occupying\\ the\\ 4th\\ ventricle\\.\ \(0\)\
\-\ \\â\\€\\¢\\ hydrocephalus\ \(0\)\
\-\ \\â\\€\\¢\\ tiny\\ nodules\\ of\\ abnormal\\ leptomeningeal\\ enhancement\\ adjacent\\ to\\ cervical\\ spinal\\ cord\\ and\\ in\\ the\\ interpeduncular\\ cistern\\.\ \(0\)\
\-\ medulloblastoma\\ with\\ leptomeningeal\\ spread\ \(0\)\
\-\ \\â\\€\\¢\\ medulloblastoma\\ \\(pnet\\)\ \(0\)\
\-\ \\â\\€\\¢\\ ependymoma\ \(8\)\
\-\ \\â\\€\\¢\\ astrocytoma\ \(1\)\
\-\ \\â\\€\\¢\\ choroid\\ plexus\\ papilloma\ \(4\)\
\-\ 2\\ year\\ old\\ boy\\ with\\ a\\ 1\\ month\\ history\\ of\\ ataxia\\ and\\ nausea\\ and\\ vomiting\\.\ \(1\)\
\-\ the\\ most\\ common\\ posterior\\ fossa\\ masses\\ are\\ astrocytoma\\ and\\ medulloblastoma\\ \\(pnet\\ \\-\\ primitive\\ neuroectodermal\\ tumor\\)\\.\\ \\ astrocytomas\\ are\\ most\\ often\\ fluid\\ secreting\\ pilocytic\\ astrocytoma\\,\\ who\\ gr1\\,\\ and\\ lateral\\ in\\ the\\ cerebellar\\ hemisphere\\.\\ \\ midline\\ masses\\ involving\\ the\\ fourth\\ ventricle\\ are\\ usually\\ medullblastoma\\,\\ that\\ arise\\ in\\ the\\ vermis\\ and\\ secondarily\\ invade\\.\\ \\ measured\\ by\\ incidence\\,\\ ependymoma\\ is\\ in\\ third\\ place\\.\\ pmid\\:\\ 16088251\\ pmid\\:\\ 19082611\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ medulloblastoma\\:\\ 0\\.10202816758061177\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.07513082507651517\ \(0\)\
\-\ pmid\\:\\ 0\\.07371960574631989\ \(0\)\
\-\ pnet\\:\\ 0\\.07093057896219332\ \(0\)\
\-\ leptomeningeal\\:\\ 0\\.0695595726805908\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.06818527805493074\ \(0\)\
\-\ ataxia\\:\\ 0\\.06256196139612519\ \(0\)\
\-\ gr1\\:\\ 0\\.06038026317785272\ \(0\)\
\-\ medullblastoma\\:\\ 0\\.06038026317785272\ \(0\)\
\-\ 16088251\\:\\ 0\\.06038026317785272\ \(0\)\
\-\ 19082611\\:\\ 0\\.06038026317785272\ \(0\)\
\-\ ependymoma\\:\\ 0\\.052398436125859746\ \(0\)\
\-\ secondarily\\:\\ 0\\.047052111471994416\ \(0\)\
\-\ interpeduncular\\:\\ 0\\.04533077977144026\ \(0\)\
\-\ ventricle\\:\\ 0\\.04386836051477298\ \(0\)\
\-\ secreting\\:\\ 0\\.04336035461766094\ \(0\)\
\-\ invade\\:\\ 0\\.04336035461766094\ \(0\)\
\-\ neuroectodermal\\:\\ 0\\.04138992946388162\ \(0\)\
\-\ astrocytomas\\:\\ 0\\.04058319634294749\ \(0\)\
\-\ masses\\:\\ 0\\.03956975887665873\ \(0\)\
\-\ primitive\\:\\ 0\\.03806453346537682\ \(0\)\
\-\ vermis\\:\\ 0\\.03708439070071467\ \(0\)\
\-\ tiny\\:\\ 0\\.036642346035388844\ \(0\)\
\-\ occupying\\:\\ 0\\.036431581250000115\ \(0\)\
\-\ intraventricular\\:\\ 0\\.03400938919353726\ \(0\)\
\-\ measured\\:\\ 0\\.031788569548430554\ \(0\)\
\-\ cistern\\:\\ 0\\.031280980698062594\ \(0\)\
\-\ pilocytic\\:\\ 0\\.03080842678376841\ \(0\)\
\-\ deficit\\:\\ 0\\.030197254634946883\ \(0\)\
\-\ choroid\\:\\ 0\\.02987103512132185\ \(0\)\
\-\ hemisphere\\:\\ 0\\.02979185140624599\ \(0\)\
\-\ 4th\\:\\ 0\\.02948396518801129\ \(0\)\
\-\ papilloma\\:\\ 0\\.029409108540530533\ \(0\)\
\-\ arise\\:\\ 0\\.028976376337643328\ \(0\)\
\-\ plexus\\:\\ 0\\.0284388995195509\ \(0\)\
\-\ place\\:\\ 0\\.0284388995195509\ \(0\)\
\-\ spread\\:\\ 0\\.028310871211248482\ \(0\)\
\-\ fourth\\:\\ 0\\.028310871211248482\ \(0\)\
\-\ most\\:\\ 0\\.027025138927781862\ \(0\)\
\-\ incidence\\:\\ 0\\.02683341523298347\ \(0\)\
\-\ neurological\\:\\ 0\\.02532551103801194\ \(0\)\
\-\ pending\\:\\ 0\\.02532551103801194\ \(0\)\
\-\ cerebellar\\:\\ 0\\.02524397060988647\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.02516338950317697\ \(0\)\
\-\ nodules\\:\\ 0\\.024263827845224323\ \(0\)\
\-\ excision\\:\\ 0\\.024022265250447213\ \(0\)\
\-\ are\\:\\ 0\\.02393576450403291\ \(0\)\
\-\ fossa\\:\\ 0\\.023854791991103623\ \(0\)\
\-\ nausea\\:\\ 0\\.023563287782755703\ \(0\)\
\-\ third\\:\\ 0\\.023468812973630116\ \(0\)\
\-\ midline\\:\\ 0\\.022644726625606307\ \(0\)\
\-\ vomiting\\:\\ 0\\.022346293418115618\ \(0\)\
\-\ cord\\:\\ 0\\.02224091726168083\ \(0\)\
\-\ cervical\\:\\ 0\\.021267749360216633\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.02097908072014291\ \(0\)\
\-\ spinal\\:\\ 0\\.020957371303969765\ \(0\)\
\-\ involving\\:\\ 0\\.02053703605481708\ \(0\)\
\-\ boy\\:\\ 0\\.0198953546570272\ \(0\)\
\-\ often\\:\\ 0\\.018674476359723646\ \(0\)\
\-\ adjacent\\:\\ 0\\.018505727699549775\ \(0\)\
\-\ enhancing\\:\\ 0\\.018355846115649034\ \(0\)\
\-\ usually\\:\\ 0\\.01777348119086821\ \(0\)\
\-\ month\\:\\ 0\\.017559003704113764\ \(0\)\
\-\ focal\\:\\ 0\\.016715709617386314\ \(0\)\
\-\ abnormal\\:\\ 0\\.016692412604896654\ \(0\)\
\-\ fluid\\:\\ 0\\.016634514415094885\ \(0\)\
\-\ enhancement\\:\\ 0\\.015688279220020793\ \(0\)\
\-\ \\:\\:\\ 0\\.01548321665740637\ \(0\)\
\-\ common\\:\\ 0\\.015316898712030116\ \(0\)\
\-\ who\\:\\ 0\\.015260057596860973\ \(0\)\
\-\ 1\\:\\ 0\\.013926892931230868\ \(0\)\
\-\ tumor\\:\\ 0\\.01364542672336172\ \(0\)\
\-\ posterior\\:\\ 0\\.01349067499111266\ \(0\)\
\-\ lateral\\:\\ 0\\.012648411271401028\ \(0\)\
\-\ 2\\:\\ 0\\.012603455455551686\ \(0\)\
\-\ \\-\\:\\ 0\\.012546085333618928\ \(0\)\
\-\ surgical\\:\\ 0\\.012302888837338722\ \(0\)\
\-\ in\\:\\ 0\\.011545129592883696\ \(0\)\
\-\ that\\:\\ 0\\.010109457044923447\ \(0\)\
\-\ \\(\\:\\ 0\\.009895366112929595\ \(0\)\
\-\ \\)\\:\\ 0\\.009774488933058973\ \(0\)\
\-\ by\\:\\ 0\\.00974569111811558\ \(0\)\
\-\ mass\\:\\ 0\\.008140143883202496\ \(0\)\
\-\ history\\:\\ 0\\.008083661217171804\ \(0\)\
\-\ \\,\\:\\ 0\\.007416714123761298\ \(0\)\
\-\ and\\:\\ 0\\.0073976303725569225\ \(0\)\
\-\ year\\:\\ 0\\.006548666227896676\ \(0\)\
\-\ old\\:\\ 0\\.00599270271823462\ \(0\)\
\-\ no\\:\\ 0\\.005893453087012342\ \(0\)\
\-\ the\\:\\ 0\\.005681477453573663\ \(0\)\
\-\ is\\:\\ 0\\.003851306701265244\ \(0\)\
\-\ to\\:\\ 0\\.0029251240304314125\ \(0\)\
\-\ a\\:\\ 0\\.002716436998757543\ \(0\)\
\-\ \\.\\:\\ 0\\.002431475075160704\ \(0\)\
\-\ with\\:\\ 0\\.0016027969327382155\ \(0\)\
\-\ of\\:\\ 0\\.001595942476684773\ \(0\)\
